The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of different therapeutic modalities for patients with metachronous oligometastatic renal-cell carcinoma (RCC): Analyses of a single-institution database.
 
Antonio Cigliola
No Relationships to Disclose
 
Chiara Re
No Relationships to Disclose
 
Brigida Anna Maiorano
Research Funding - Merck
Travel, Accommodations, Expenses - Ipsen; Janssen; Novartis; Pfizer
 
Valentina Tateo
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen; Merck
 
Antonio Nuccio
No Relationships to Disclose
 
Chiara Mercinelli
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen
 
Chiara Deantoni
No Relationships to Disclose
 
Giovanni Luigi Pastorino
No Relationships to Disclose
 
Giorgio Brembilla
No Relationships to Disclose
 
Maurizio Colecchia
No Relationships to Disclose
 
Francesco De Cobelli
No Relationships to Disclose
 
Nadia Di Muzio
No Relationships to Disclose
 
Alessandro Larcher
Research Funding - Intuitive Surgical; VHL Alliance
Travel, Accommodations, Expenses - AB Medica
 
Giuseppe Rosiello
No Relationships to Disclose
 
Alberto Briganti
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Ferring; Hauora; Janssen-Cilag; MDxHealth; OPKO Health; Pfizer
Speakers' Bureau - Astellas Pharma
Research Funding - Merck Sharp & Dohme; Sandoz-Novartis
 
Francesco Montorsi
No Relationships to Disclose
 
Umberto Capitanio
No Relationships to Disclose
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Consulting or Advisory Role - AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Catalym; Genenta Science; Gilead Sciences; Incyte; Johnson & Johnson/Janssen; Merck Serono; Merck Sharp & Dohme; Peerview; PeerVoice; Samsung Bioepis; Seattle Genetics/Astellas
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Gilead Sciences (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Janssen; Merck Sharp & Dohme